retatrutide mechanism triple agonist glp-1 gip glucagon Reta clinical trial data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, A Clinician's Guide to Retatrutide
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




















![How Stonehenge Health® Saved $1M in 1 Year by Switching to ShipBob Plus [Case Study]](https://www.shipbob.com/wp-content/uploads/2026/03/e01edfb85c6b94277af4e3d87484d747-e1773694612896.webp)







